Search
Standards

Most Common Noncomformities Written During ISO 13485 Audits

Commitment to quality

Most Common Noncomformities Written During ISO 13485 Audits

Navigating an ISO 13485 audit requires more than just following a checklist; it demands a deep understanding of medical device-specific requirements and a robust commitment to documentation. In this webinar, we explore why organizations are often deemed “not ready” during Stage 1 and identifies the most frequent Non-Conformance Reports (NCRs) issued during Stage 2 and surveillance audits.

Avoiding Stage 1 Pitfalls: Ensuring Readiness

A successful certification journey begins with a solid Stage 1 foundation. Common reasons for being deemed unready to proceed include:

  • Poor Planning: Organizations often fail to leave enough time between Stage 1 and Stage 2. PJR recommends a window of six weeks to 90 days to address any concerns identified in the initial phase
  • Missing Documented Procedures: Unlike ISO 9001:2015, which has reduced its reliance on formal procedures, ISO 13485 maintains a heavy requirement for documented processes due to the critical nature of the industry
  • Immature Objectives: Quality objectives must be measurable, and auditors need to see enough data to identify trends and evaluate the organization’s response to those trends
  • Shared Space Delineation: If an organization shares a facility with other companies, the boundaries and scope of the medical device management system must be clearly defined

Common NCRs During Stage 2 and Surveillance

Once an organization moves past Stage 1, several “big hitters” frequently lead to non-conformities:

  • Software Validation: A common oversight involves off-the-shelf software, such as Microsoft Excel. If these tools are used for QMS-related tracking or calculations, they must be validated for their specific application before use
  • Risk-Based Supplier Control: Supplier evaluation criteria should not be based solely on cost. Instead, selection and monitoring must be proportionate to the risk the supplier’s product poses to the final medical device
  • Identification and Traceability: Auditors frequently find issues with product status identification throughout production and the failure to distinguish non-conforming or suspect returns from conforming stock
  • Preservation of Product: This includes monitoring shelf life and ensuring that constituent parts or reagents have not expired
  • Document Control: Typical issues involve unapproved documents or unauthorized “reference only” versions being used by personnel on the shop floor

The Evolution of Auditing: Remote and Hybrid Models

This video also addresses the transition to virtual auditing. While face-to-face interaction remains highly valuable, PJR offers flexible options for partially virtual audits.

  • Benefits: Remote auditing can save clients money on travel costs and reduce the “intrusiveness” of the audit on daily operations
  • Scope: Records like design files, complaints, management reviews, and risk analyses are particularly well-suited for virtual review via screen-sharing platforms

Watch the entire video: